Menu

Stories

New subretinal implant A new subretinal implant invented by Mark Humayun has been shown to improve vision in some patients who suffered from dry age-related macular degeneration.

USC discovery shows long-term viability of stem cell derived retinal implant

Doctors and biomedical engineers who implant cells and tissues into patients to restore motion or eyesight have long been challenged by potential rejection of the implant by the patient’s own immune system. …

USC's stem cell research center

California’s biggest stem cell experiment: The impact of the stem cell ballot proposition at USC

In 2008, USC broke ground on an $80 million building dedicated solely to stem cell research and regenerative medicine. The plans called for a monolithic structure clad in black marble and reflective …

USC public symposium illustrates how to move stem cells from Petri dish to patient

Have you ever wondered how a scientific discovery in the laboratory becomes a new medical treatment for patients in the hospital? At the public symposium “Bringing Stem Cells to Patients – Treating …

From restoring sight to reversing brain damage, USC stem cell researchers are making life-changing discoveries

If anyone has a clear vision of the power of stem cell cures, it’s Anna Kuehl. She suffered a retina-wrecking disease that cost her much of her sight before USC physicians surgically …

Out of the woods: USC alumna and nature lover Anna Kuehl finds hope to restore her vision

Once upon a time, there was a little girl named Anna Kuehl who loved exploring the nature surrounding her home in the Bavarian Forest. Located northeast of Munich not far from the …

Researchers test stem cell–based retinal implant for common cause of vision loss with encouraging results

Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell–based retinal implant is feasible for use in people with advanced …

Americans for Cures animations highlight stem cell clinical trials

How do clinical trials work? With the support of Proposition 71 and the California Institute for Regenerative Medicine (CIRM), California stem cell scientists at USC and elsewhere are developing a new generation …

Americans for Cures animates stem cell research at USC and UCSD

Americans for Cures produced a white board animation showcasing a clinical trial for age-related macular degeneration, led by USC Stem Cell researchers David Hinton and Mark Humayun:

Tri-institutional Stem Cell Retreat brings together Broad centers from USC, UCLA and UCSF

Working alone, a scientist or university can only make so much progress in finding answers to basic questions or new treatments for diseases ranging from HIV to cancer to diabetes. That’s why …

Faculty Spotlight: David R. Hinton

David Hinton’s research is focused on developing novel therapies for age-related macular degeneration (AMD) – the leading cause of irreversible blindness in the elderly. He is approaching this goal in two main …

USC hosts California stem cell agency’s tenth birthday bash

Few 10 year olds have brought 10 potential medical treatments into clinical trials. The California Institute for Regenerative Medicine (CIRM), however, is a truly exceptional 10 year old. In 2004, the people …

USC stem cell PhD students present their blueprints for rebuilding the body

Video by Alric Devotta The students in the new PhD program in Development, Stem Cells, and Regenerative Medicine recently presented some ideas that would give Dr. Frankenstein a run for his money. …

Mark Humayun and David Hinton look to stem cells to bring sight to the blind

Video by Ryan Ball For years, people were throwing away cells that could bring eyesight to the blind. These dark, blackened cells looked like spots of contamination in the petri dishes in …

Clinical trial to study loss of vision

Keck Medicine of USC research to slow vision loss for macular degeneration patients has been funded as part of the third round of the California Institute for Regenerative Medicine’s (CIRM) Disease Team …